News | July 16, 2013

ImaCor Implements 24/7 hTEE Clinical Support Program

Clinical specialists available around-the-clock to provide hTEE customer service

hTEE 24/7 Clinical Support Program ImaCor

July 16, 2013 — ImaCor Inc. announced the implementation of the 24/7 hTEE Clinical Support Program.

ImaCor’s 24/7 hTEE Clinical Support Program ensures that a senior member of the company’s clinical specialist team is always available via phone, text and video-chat modalities to provide support to clinicians working at the patient bedside. 24/7 hTEE Clinical Support is an enhancement to the ImaCor Customer Service Program, and aligns with ImaCor’s educational commitment to their customers. The launch of this program coincides with the start of the critical care fellowship year.

“While introducing hTEE into our Neurointensive Care Unit, our team benefited from ImaCor's 24/7 hTEE Clinical Support Program,” commented Jacqueline S. Urtecho M.D., Neurointensive Care Physician at Thomas Jefferson University Hospital. “The ability to video-chat with an hTEE clinical specialist at any time complements the team’s ongoing training and ensures that we can apply hTEE confidently whenever our patients need it.”

“Around-the-clock guidance is often necessary during the implementation of new technologies,” said Donald Reiff M.D., director of the Trauma/Burn Unit at the University of Alabama Hospital at Birmingham. “ImaCor’s 24/7 hTEE Clinical Support Program is a best practice in the business, enabling any member of our team — including Fellows and Physician Assistants — to connect with an ImaCor hTEE specialist for day or night support.”

hTEE is the only technology in critical care that provides continuously available, direct visualization of heart filling and function in the ICU, enabling optimal post-operative hemodynamic management.

For more information: www.imacorinc.com


Related Content

News | Transesophageal Echo (TEE)

June 13, 2024 — Visura Technologies, Inc., a privately owned medical device company, has announced the TEECADE mini, an ...

Home June 13, 2024
Home
News | Transesophageal Echo (TEE)

May 29, 2024 — Congenital heart disease (CHD) is one of the most common congenital anomalies worldwide, which brings a ...

Home May 29, 2024
Home
News | Transesophageal Echo (TEE)

January 31, 2024 — Royal Philips, a global leader in health technology, announced that its latest TEE transducer ...

Home January 31, 2024
Home
News | Transesophageal Echo (TEE)

June 30, 2022 — Clarius Mobile Health, a leading provider of high-definition wireless ultrasound systems, and ImaCor Inc ...

Home June 30, 2022
Home
News | Transesophageal Echo (TEE)

June 7, 2022 — Visura Technologies, Inc., a privately-held medical device company dedicated to delivering state-of-the ...

Home June 07, 2022
Home
News | Transesophageal Echo (TEE)

February 5, 2019 – The American Society of Echocardiography (ASE) released a new document that provides a comprehensive ...

Home February 05, 2019
Home
Sponsored Content | Case Study | Transesophageal Echo (TEE) | Cyril Danielkutty B.E., Dillon Weiss, B.S., Chad A Kliger, M.D., M.S.

Transcatheter interventions have become a mainstay in cardiac care as treatments for structural and congenital heart ...

Home September 05, 2018
Home
Technology | Transesophageal Echo (TEE)

July 10, 2018 — Evanston, Ill.-based startup Visura Technologies has received 510(k) clearance from the U.S. Food and ...

Home July 10, 2018
Home
Technology | Transesophageal Echo (TEE)

June 20, 2017 — Dutch medical device company Stroke2prevent BV recently announced it has received U.S. Food and Drug ...

Home June 20, 2017
Home
News | Transesophageal Echo (TEE)

April 21, 2016 — CS Medical announced the release of their newest product designed to aid in the circle of care for ...

Home April 21, 2016
Home
Subscribe Now